Evidence map›Paper›PMID 38202344›Full record

ArticlePlants (Basel, Switzerland)2023

Enhanced Cytotoxicity and Antimelanoma Activity of Novel Semisynthetic Derivatives of Betulinic Acid with Indole Conjugation.

Adelina Lombrea, Claudia Geanina Watz, Larisa Bora, Cristina Adriana Dehelean, Zorita Diaconeasa, Stefania Dinu, Māris Turks, Jevgeņija Lugiņina, Uldis Peipiņš, Corina Danciu

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. FeNanomaterials (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Cutaneous Evaluation of FeInternational journal of nanomedicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Adelina LombreaDepartment of Pharmacognosy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.ORCID 0000-0002-6576-965X
Claudia Geanina WatzResearch Center for Pharmaco-Toxicological Evaluation, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.ORCID 0000-0002-2498-4732
Larisa BoraDepartment of Pharmacognosy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.ORCID 0000-0002-9367-4770
Cristina Adriana DeheleanResearch Center for Pharmaco-Toxicological Evaluation, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
Zorita DiaconeasaDepartment of Biochemistry, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania.ORCID 0000-0002-5325-3859
Stefania DinuDepartment of Pedodontics, Faculty of Dental Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, 9 No., Revolutiei Bv., 300041 Timisoara, Romania.ORCID 0000-0002-4351-7726
Māris TurksInstitute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, P. Valdena Str. 3, LV-1048 Riga, Latvia.ORCID 0000-0001-5227-0369
Jevgeņija LugiņinaInstitute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, P. Valdena Str. 3, LV-1048 Riga, Latvia.ORCID 0000-0001-8147-9698
Uldis PeipiņšInstitute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, P. Valdena Str. 3, LV-1048 Riga, Latvia.
Corina DanciuDepartment of Pharmacognosy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.ORCID 0000-0001-5999-1214
Victor Babeș University of Medicine and Pharmacy Timișoara · RORiga Technical University · LVLatvia University of Life Sciences and Technologies · LVUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence and severity of skin cancer, specifically malignant melanoma, among Caucasians remains a significant concern. Natural compounds from plants have long been explored as potential anticancer agents. Betulinic acid (BI) has shown promise in its therapeutic properties, including its anticancer effects. However, its limited bioavailability has hindered its medicinal applications. To address this issue, two recently synthesized semisynthetic derivatives,

Indexed as

2,3-indolo-betulinic acidB164A5 murine melanoma cellsglycine conjugatesmelanoma

Identifiers

PMID38202344
PMCPMC10780819
OpenAlexW4390061677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.